Vaccine

AI in Life Sciences Market Poised for Explosive Growth with 27.9% CAGR Through 2029

AI Revolutionizes Life Sciences: Transforming Drug Discovery, Personalized Medicine, and Patient Outcome. BCC Research Study Projects a 27.9% CAGR, with…

3 months ago

Cleanroom Technologies Market to Hit USD 12.3 Billion by 2029 with 6.9% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 26, 2024 /PRNewswire/ -- The global cleanroom technologies market is set to grow from USD 8.8 billion…

3 months ago

2024 Collegiate Inventors Competition Finalists Showcase the Future of American Innovation

NORTH CANTON, Ohio, Sept. 26, 2024 /PRNewswire/ -- The Collegiate Inventors Competition®, an annual competition that has rewarded innovations, discoveries…

3 months ago

Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts

GAITHERSBURG, Md., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent”) today announced that two contract options have…

3 months ago

Repair Biotechnologies and Genevant Sciences to Collaborate to Develop mRNA-LNP Therapy with First-in-Class Potential to Turn Back Atherosclerosis

SYRACUSE, New York, VANCOUVER, British Columbia, and BASEL, Switzerland, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Repair Biotechnologies, a biotechnology company…

3 months ago

Vanderbilt University School of Medicine Basic Sciences Adds Carterra’s LSAXT Instrument to Speed Drug and Vaccine Research and Advance Patient Care

The Center for Structural Biology in the School of Medicine Basic Sciences will be a hub of research innovation using Carterra's…

3 months ago

Africa CDC and IAVI Sign Memorandum of Understanding to Enhance Vaccine and Antibody Research Capacity in Africa

NEW YORK, NY / ACCESSWIRE / September 25, 2024 / The Africa Centres for Disease Control and Prevention (Africa CDC)…

3 months ago

Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split

PRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (“Sonnet” or the “Company”) (NASDAQ: SONN), a biopharmaceutical…

3 months ago

Cidara Therapeutics Announces Two Presentations on Innovative Drug-Fc Conjugate, CD388, at the 2024 OPTIONS XII for the Control of Influenza Conference

SAN DIEGO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform…

3 months ago

Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts

$185+ million in incremental orders for ACAM2000® and VIGIV to be delivered in 2024 and 2025GAITHERSBURG, Md., Sept. 25, 2024…

3 months ago